News from NORD

Patients Are Being Recruited for LPL-Deficiency Study


 

Adult patients with lipoprotein lipase deficiency (LPLD) in the US and Canada may be eligible for a study of alipogene tiparvovec. LPLD is a rare, autosomal recessive disorder of lipid metabolism. Additional information can be found on clinicaltrials.gov under study ID NCT02904772.

Recommended Reading

NORD to Develop Natural History Studies With 20 Rare Disease Patient Organizations
MDedge Endocrinology
$6.8 Million Awarded to Study the Biology of Rare and Undiagnosed Diseases
MDedge Endocrinology
Beloranib reduces weight in Prader-Willi syndrome, but concerns remain
MDedge Endocrinology
Adrenal gland tumors linked to ADHD diagnosis
MDedge Endocrinology
Enlist appropriate psychological consults for gender dysphoria
MDedge Endocrinology
Study identifies important predictors for PC/PGL
MDedge Endocrinology
European Commission’s proposed criteria for endocrine disruptors trigger multiple concerns
MDedge Endocrinology
NORD Urges Congress to Pass 21st Century Cures Act
MDedge Endocrinology
Nominate a Colleague for a NORD 2017 Rare Impact Award
MDedge Endocrinology
Presentation Chronicles Pathway to Erdheim-Chester Diagnosis
MDedge Endocrinology